Introducing: Stock Movers Podcast

Check out the new Stock Movers Podcast from Bloomberg. Subscribe for five-minute episodes on today's winners and losers in the stock market.   

Listen on Apple: https://apple.co/4kJ43ON   
Listen on Spotify: https://tinyurl.com/mr385jv6   
Listen on other platforms: https://link.podtrac.com/h0zn7xir

See omnystudio.com/listener for privacy information.

Episode Transcript

Speaker 1 (00:00):
Hi, I'm Alex Steele introducing you to the new Stock
Movers podcast from Bloomberg, the show that brings you short
episodes five minutes or less, covering the stocks making gains
and losses in today's trading. Subscribe to Stock Movers on Apple, Spotify,
or wherever you get your podcasts.

Speaker 2 (00:14):
Now.

Speaker 1 (00:14):
Here's a sample of the latest episode from our team at.

Speaker 3 (00:17):
Bloomberg Bloomberg Audio Studios, Podcasts, radio News.

Speaker 4 (00:26):
The Stock Movers podcast your roundup of companies making moves
in the stock market, harnessing the power of Bloomberg data.

Speaker 2 (00:35):
Let's look at some stocks on the move today. We
are joined by Bloomberg's Critty Gupta on a choppy pre
market session for stocks as a whole creaty. That is
certainly what we are seeing at the micro level. For Delta,
they just reported earnings. What's the stock doing?

Speaker 3 (00:50):
Good morning, Good morning, Nathan. We are getting the very
first inclination of companies starting to suspend their guidance. This
is a really big deal. I'm having a little bit
of COVID deja vus here because when you look at
some of these numbers, the earnings revisions are key to
that chart you've seen massive numbers, massive hits to the
tech valuations. A lot of that is only if you

(01:11):
do indeed get those earnings revisions from these companies, or
like in COVID, you do get a suspension of the
guide of guidance there as well. So Delta d AL
is your ticker this morning, actually coming out of the
gates hire by about three percent. The market is buying this,
which is non traditional, giving that they're withdrawing. They're full
of your guidance, calling it given current uncertainty. They're saying

(01:33):
that growth has largely stalled. But when you look at
their first quarter numbers, they are actually coming in line
with expectation. So the markets buying even just that is
quite something to witness because again a very non traditional
reaction for really any company that would be suspending it's guidance.
Let's talk about some of the other weights in this market.
I think the story of the morning, your pharma stocks

(01:55):
are taking the biggest beating this morning. I'm just going
to run through the laundry list of names this morning. Nathan,
if I can, Aby is top of that list. ABBV
is your ticker, down just shy of four percent this morning,
one hundred and sixty nine dollars to share, Abbot right
on its heels, ABT down about the same margin, trading
at one hundred and nineteen dollars a share.

Speaker 4 (02:14):
There.

Speaker 3 (02:14):
Then you've got Gilliad Sciences as well, Gild down about
three percent. I'm seeing if their bonds are selling off
in a very big way this morning. Really keep an
eye on a on a stock simply because or some
of the kind of bonds that are trading. Credit seems
to be leading this equity market. So anything that has
a massive corporate bond hit is going to be magnified
in the equity market. You're seeing that with Gilliad Sciences,

(02:35):
like I said, Gild down about three percent, Bristol Meyers
squib as well, Bmy down about three percent, trading at
fifty one dollars a share, and some of our favorites
there Pfizer PFE down a whopping three percent, trading at
twenty one dollars share. Nathan, I could go on and on.
The message this morning is if you are a pharmaceutical hit,
you are taking a massive hit when it comes to

(02:57):
your stock. And a lot of this is lead actually
by some of the pain you've seen right here in
Europe as well. The likes of Nova Nordisk, for example,
have really been selling off this morning in Europe, alongside
Roche and Santa Fe as well. Nova Nordisk, I should
mention the ADRs also are available in the United States
ENVO for that ticker trading out about sixty dollars and
change down about one point two percent. I'll just mention

(03:18):
that about sixty percent of Nova Nordisk's revenue comes from
the United States, so this is a really great spot
to look at when you're talking about some of the
movement there in the pharmaceutical space. We're also getting some
numbers coming out of Walmart, several comments coming from the
CEO in the last twenty four hours thing that they're
being focused on keeping price as low, prices as low
as they possibly can, and really looking at some cost

(03:41):
cutting measures. They're reaffirming their first quarter sales guidance. In
their full year twenty twenty six guidance remains unchanged, so
that's going to be again another major one to watch, Nathan.
For me, Walmart's WMT is the tell those shares hire
by two percent this morning.

Speaker 4 (03:57):
The Stock Movers podcast Bloomberg Radio check Back with us
throughout the day. For the latest roundup of companies making
news on Wall Street, and for the latest market moving headlines.
Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
dot com, and on Applecarplay and Android Auto with the
Bloomberg Business app.